Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Endocrine, Metabolic & Immune Disorders Drug Targets|July 1, 2020
Roux-en-Y Gastrointestinal Bypass Promotes Activation of TGR5 and Peptide YYHaojun Yang, Hanyang Liu, YuWen Jiao, et al.
Diabetes & Metabolism Journal|November 12, 2025
LRRFIP1 Inhibits White Adipocyte Differentiation by Suppressing the E2F6/C/EBPα AxisLei Zhou, Yuwen Jiao, Jiaming Xue, et al.
Experimental and Therapeutic Medicine|August 4, 2020
Mechanism of TGF-β1 inhibiting Kupffer cell immune responses in cholestatic cirrhosisJun Qian, Yuwen Jiao, Guangyao Wang, et al.
Disease Markers|February 9, 2023
Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE AlgorithmsYicheng Jiang, Yu Wang, Shuai Chen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 31, 2022
Development of a prognostic metabolic signature in stomach adenocarcinomaYu Gong, Siyuan Wu, Sen Dong, et al.
Annals of Translational Medicine|August 25, 2021
TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathwayHaojun Yang, Fengyong Luo, Yi Wei, et al.
Pageof 3